Statin use does not reduce risk of acute kidney injury following cardiac surgery |
Abbott initiates voluntary MitraClip delivery system safety notice |
AHA enacts tougher anti-smoking policy for cities hosting its conferences |
Women have lower one-year mortality rates after TAVR with the Sapien valve |
Most FDA-approved high-risk cardiovascular device studies are published in peer-reviewed literature |
As FDA commissioner, Califf plans on focusing on evidence-based medicine |
ACC releases lifelong learning competencies document for cardiologists |
Physicians preach caution when interpreting and implementing SPRINT trial results |
Boston Scientific chairman and co-founder to retire in May; CEO will replace him |
Senate confirms Califf as FDA commissioner |
FDA approves Boston Scientific’s quadripolar leads |
Death rates associated with in-hospital cardiogenic shock following acute MI decline in recent years |
FDA rejects expanded indications for Merck cholesterol drugs |
High-dose tirofiban during PCI is associated with significant reduction in all-cause mortality |
Stenting and endarterectomy have similar outcomes in asymptomatic patients with severe carotid stenosis |
After stroke, Pioglitazone reduces risk of MI or subsequent stroke |
Neurological improvement following strokes may still lead to unfavorable outcomes |
Boston Scientific Receives CE Mark For Eluvia™ Drug-Eluting Vascular Stent and Announces Initiation of New Clinical Trial |
Medtronic Receives CE Mark for Full Line of Cardiac Resynchronization Therapy-Defibrillators Compatible with MRI Scans |
Untreated hypertension leads to increased risk of intracerebral hemorrhage |
Hospital reimbursement for alteplase does not match up with increased costs |
DOJ reaches settlements with 51 hospitals for allegedly improperly implanting ICDs |
Therox Enrolls First Patient in Study of Next-Generation Supersaturated Oxygen Therapy for Ami |
Medtronic increases cash dividend 25 percent for fiscal year’s fourth quarter |
FDA approves St. Jude Medical’s pacing technology, leads and quartet test |
Mended Hearts launches LVAD video contest |
Stryker agrees to acquire Physio-Control for $1.28 billion |
ACC, AHA express concern with conflicting blood pressure measure sets |
Stroke researchers and scientists receive national awards |
International stroke conference features more than 1,500 presentations |
Nearly 17 million U.S. adults may benefit from lowering systolic blood pressure goal |
Paris Cardiology Center Improves Cath Lab Offering with Toshiba’s Cardiovascular X-ray |
Senate plans on holding a procedural vote on Califf’s nomination for FDA commissioner |
Model finds the CardioMEMS device is cost-effective for heart failure patients |
Harvard researchers examine PCI readmission metric |
Cook Medical voluntarily recalls catheters, pressure monitoring sets and trays |
Software Leaders Collaborate to Develop Powerful Cardiovascular EHR System |
IBHRE Promotes Certification among Heart Rhythm Examiners |
CMS decision may expand use of Watchman device in the U.S. |
Contrary to popular perception, inpatient echo may not be used enough |
ACC announces late-breaking clinical trials for annual scientific session |
Hospital ratings at a glance |
Novartis agrees to pay-for-performance agreements with insurers to cover heart failure drug |
CMS releases national coverage determination for Watchman and other LAA devices |
New Real-World Comparison Showing Similar Efficacy Between the Lutonix® and In.Pact™ Drug-Coated Balloons Featured at LINC 2016 |
TAVR procedure saves Selma’s first black police chief |
Abiomed’s quarterly revenue increases 38% |
Prices of pacemakers, defibrillators and other devices are declining |
FDA grants Spectranetics bridge occlusion balloon 510(k) clearance |
Spectranetics Receives FDA 510(k) Clearance for Bridge™ Occlusion Balloon for Lead Extraction Procedures |
FDA approves Medtronic's MRI conditional CRT defibrillators for heart failure patients |
Edwards Lifesciences agrees to repurchase $325 million of its common stock |
Boston Scientific’s revenue and earnings per share increase in Q4 |
Merit Medical acquires vascular access system for $18.5 million |
Endologix, Inc. and TriVascular Technologies, Inc. Complete Merger |
Text messaging interventions may improve medication adherence |
Edwards Lifesciences’ TAVR sales increase 25 percent in fourth quarter |
Pediatric hospital stops conducting elective heart surgeries pending internal review |
Abbott acquires Kalila Medical, expands heart rhythm disorder portfolio |
Trial results show mortality rates following TAVR decreased over time |
Medtronic acquires privately held company to expand renal care business |
University Medical Center New Orleans Implements Stereotaxis Platform for Advanced Treatment of Cardiac Arrhythmias |
Seven researchers receive nearly $800,000 to examine congenital heart defect |
Most U.S. adults do not know exercise guidelines for preventing heart disease |
Sales of MitraClip device increase in Q4 |